bpc-157 / tb-500 / ghk-cu blend (5mg) + (5mg) + KPV (10mg) + (5mg) Recovery Blend - Peptides for

tractsimilar to how its processed when food is your source

Research systematically characterising the structure-activity relationships of Thymosin Beta-4 through deletion and substitution analysis validated TB-500s sequence as the minimal active fragment retaining full biological activity and confirming that the 17 amino acid actin-binding domain peptide reproduces the wound healing, cell migration, and angiogenic effects of intact Thymosin Beta-4 in relevant assay systems

Promotes Healthy Skin, Hair, and Nails by supporting cell production

Disclaimer: BPC-157 is not an FDA-approved drug, and the Food and Drug Administration has not evaluated statements regarding its effects

Research Highlights Animal Studies : Genetically obese rats treated with AOD-9604 showed significant fat loss, confirming its lipolytic effect via 3-adrenergic pathways